Clinical Trial Update: Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial evaluating avacopan in combination with a rituximab- or cyclophosphamide-containing regimen for ANCA-associated vasculitis in children…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis

Drugs mentioned

• Avacopan (avacopan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Rituximab (rituximab)

Snippet

Sponsor: Amgen | Conditions: Vasculitis | Phase 3 | Status: RECRUITING